In early December 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer/BioNTech and Moderna/NIAID mRNA COVID-19 shots to include administration of the Omicron COVID booster shots to children as young as six months old. The action allows...
Copy and paste this URL into your WordPress site to embed